Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sumitomo Dainippon Pharma Co ( (JP:4506) ) just unveiled an update.
Sumitomo Pharma Co., Ltd. reported a significant finance income for the third quarter of the fiscal year ending March 31, 2025, driven by a foreign exchange gain of 14,975 million yen due to currency fluctuations affecting its overseas subsidiaries. This financial development reflects positively on the company’s financial health and can potentially enhance its competitive positioning in the pharmaceutical industry.
More about Sumitomo Dainippon Pharma Co
Sumitomo Pharma Co., Ltd. is a pharmaceutical company based in Osaka, Japan. It is involved in the development, manufacturing, and marketing of pharmaceutical products and operates in the global market.
YTD Price Performance: 5.62%
Average Trading Volume: 3,845
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.48B
Learn more about 4506 stock on TipRanks’ Stock Analysis page.
